The QualityStocks Daily Stock List
- Medicine Man Technologies, Inc. (MDCL)
- Provectus Biopharmaceuticals, Inc. (PVCT)
- Delcath Systems, Inc. (DCTH)
- TechCare Corp. (TECR)
- Northsight Capital, Inc. (NCAP)
- MGX Minerals, Inc. (MGXMF)
- SilverSun Technologies, Inc. (SSNT)
- Flexpoint Sensor Systems, Inc. (FLXT)
- Novo Resources Corp. (NSRPF)
- Rise Gold Corp. (RYES)
- Planet 13 Holdings, Inc. (PLNHF)
- Petro River Oil Corp. (PTRC)
- InPlay Oil Corp. (IPOOF)
- Integrated Cannabis Company, Inc. (ICNAF)
Medicine Man Technologies, Inc. (MDCL)
Stockwatch, Simply Wall St, Daily Marijuana Observer, InvestorsHub, The Street, Insider Financial, Stockopedia, Marketbeat, technical420, Stockhouse, Insider Tracking, CFN Media Group, MarketWatch, and GuruFocus reported beforehand on Medicine Man Technologies, Inc. (MDCL), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Medicine Man Technologies, Inc. represents and licenses the cultivation and dispensary Intellectual Property (IP) of Medicine Man, a well-respected Tier III operator in the State of Colorado. Medicine Man cultivates and sells by way of its parent company Medicine Man Denver, the largest cultivation/retail facility in Colorado. Medicine Man has completed and totally integrated three acquisitions, which are Pono Publications, Success Nutrients, and the Denver Consulting Group. OTCQX-listed, Medicine Man Technologies is headquartered in Denver, Colorado.
The Company provides cultivation consulting services for cannabis growing technologies and methodologies. Medicine Man is one of the nation's leading cannabis brand development and consulting businesses. It is focusing on working with clients to use its experience, technology, and training to help secure licenses in States with newly emerging regulations. In addition, Medicine Man is concentrating on cultivation practices via its deployment of Cultivation MAX and eliminating the liability of single grower dependence.
Medicine Man works closely with industry-leading extraction partners. These partners provide the required licensing service support and formulations to assist customers with their planned deployment of a successful processing facility.
Medicine Man's risk-averse cannabis cultivation technology delivers consistent, high quality, high yield production within a clean-room style environment. The Company's state-of-the art dispensary model ensures patients and consumers have safe and secure access to an array of medical and/or recreational cannabis products.
Furthermore, Medicine Man is continuing the expansion of its Brands Warehouse concept. The Company also engages in retail operations of cannabis products. Moreover, it provides general business and referral management for other related service providers for its customers.
Medicine Man Technologies and Solis Tek, Inc. have a cooperative agreement. Solis Tek becomes Medicine Man's recommended supplier of High Intensity Discharge (HID) lighting technologies for its present and prospective consulting and sales relationships. Also, Medicine Man Technologies has acquired the Big Tomato retail supplier business. The Big Tomato retail business carries a broad variety of grow related products. It will additionally be acting as another distribution hub for Medicine Man's Success Nutrients product line.
Last month, Medicine Man Technologies announced that it signed binding term sheets and conditions for the acquisition of MedPharm Holdings, LLC. MedPharm is an intellectual property development and holding company centered on cannabis research and product/brand development. MedPharm provides extraction expertise, cannabis pharmaceutical-grade dosage forms using current "Good Manufacturing Practices'', which include pre-formulation; formulation development; commercial manufacturing; analytical method development and validation; and routine quality control analysis and stability studies.
In addition, in January, Medicine Man Technologies announced a binding agreement anticipated to lead to the near-term acquisition of the Colorado licensee, Medicine Man Denver (MMD). MMD is one of the pioneering operators that helped establish the expanding cannabis industry over the past 10 years, with brand recognition well beyond its immediate market.
MMD's operations include one of the largest indoor cultivations in Colorado and four retail locations with combined sales that have kept it in the top tier of operators in Colorado. The final acquisition will require the approval of the Marijuana Enforcement Division (MED) in the State of Colorado, and also local city and county rules regarding the transfer and sale of ownership interest.
Medicine Man Technologies, Inc. (MDCL), closed Monday's trading session at $2.50, up 12.61%, on 180,955 volume with 390 trades. The average volume for the last 3 months is 120,881 and the stock's 52-week low/high is $1.06/$2.53.
Provectus Biopharmaceuticals, Inc. (PVCT)
Top Stock Analysts, Club Penny Stocks Network, The Street, Streetwise Reports, All Penny Stocks, Stock News Now, Wise Alerts, plrinvest, Investors Underground, Real Pennies, PennyStocks24, Top Penny Stock Movers, Street Insider, Street Authority Daily, and The Microcap News reported previously on Provectus Biopharmaceuticals, Inc. (PVCT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Provectus Biopharmaceuticals, Inc. is a clinical-stage oncology and dermatology Biopharmaceutical Company. It is developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. The Company`s investigational oncology drug is PV-10. PV-10 is an oncolytic immunotherapy enrolling patients in Phase 3 clinical trials for metastatic melanoma. Provectus Biopharmaceuticals has its head office in Knoxville, Tennessee.
PV-10 is an ablative immunotherapy under investigation in solid tumor cancers. PV-10 is a 10 percent solution of small molecule and halogenated xanthene Rose Bengal. It undergoes administration through direct injection into solid tumor cancers, including melanoma, liver, and breast. It is not designed to rely on a single pathway, receptor or antigen to work. There is no known resistance.
The intention of PV-10 is to kill only diseased cells upon injection into tumors. Provectus Biopharmaceuticals has received orphan drug designations from the Food and Drug Administration (FDA) for its melanoma and hepatocellular carcinoma indications. The Company completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis.
PH-10 is a topical investigational drug for dermatology and is a topical hydrogel formulation. It yields selective delivery of rose bengal disodium to epithelial tissues. Regarding PH-10 for psoriasis and atopic dermatitis, a mechanism of action study is underway to measure the clinical and cellular response to PH-10's active investigational agent. A total of 226 subjects have been treated with PH-10 in Phase 1 or Phase 2 Clinical Trials.
Provectus Biopharmaceuticals announced this past November that it was granted orphan drug designation (ODD) by the FDA for small molecule oncolytic immunotherapy PV-10 for the treatment of neuroblastoma. This is a non-Central Nervous System (CNS) pediatric solid tumor. Intratumoral injection of PV-10 can yield immunogenic cell death (ICD) in solid tumor cancers and stimulate tumor-specific reactivity in circulating T cells. ODD status was earlier granted to PV-10 for the treatments of metastatic melanoma in 2007 and hepatocellular carcinoma (HCC) in 2013.
Last week, Provectus Biopharmaceuticals announced that orphan drug designation (ODD) status was granted by the FDA to small molecule oncolytic immunotherapy PV-10 for the treatment of ocular melanoma (to include all melanoma disease affecting the eye and orbit). The FDA grants ODD status to medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect less than 200,000 people in the United States. ODD status qualifies companies for certain benefits. These benefits include seven years of market exclusivity following marketing approval, tax credits on U.S. clinical trials, eligibility for orphan drug grants, as well as waiver of certain administrative fees.
This week, Provectus Biopharmaceuticals and the Pediatric Oncology Experimental Therapeutics Investigators Consortium (POETIC) announced that OncoTargets and Therapy (OTT) published preclinical results from in vitro and animal tumor model studies on PV-10 for the treatment of neuroblastoma. POETIC is a group of 10 top-tier academic medical centers developing new pediatric cancer therapies.
The work was led by Dr. Aru Narendran and his team at the University of Calgary's POETIC Preclinical and Drug Discovery Laboratory. Prior preclinical and clinical studies by other researchers have shown that intratumoral injection of PV-10 can yield immunogenic cell death in adult solid tumors and stimulate tumor-specific reactivity in circulating T cells.
According to the POETIC authors, "Our studies provide preclinical proof-of-concept data on the efficacy of PV-10 in neuroblastoma. Mechanistically, we have found that PV-10 acts by disrupting lysosomes, inducing cell cycle changes and initiating cell death by apoptosis. We have also identified several commonly used treatments with which PV-10 shows synergistic anti-tumor activity. Furthermore, we have validated the efficacy of PV-10 in vivo, using neuroblastoma xenograft mouse experiments."
Provectus Biopharmaceuticals, Inc. (PVCT), closed Monday's trading session at $0.055, even for the day, on 104,768 volume with 17 trades. The average volume for the last 3 months is 251,581 and the stock's 52-week low/high is $0.029/$0.084.
Delcath Systems, Inc. (DCTH)
OTC Markets, InvestorsHub, Proactive Investors, SuperStockScreener, Stocks Gallery, 4-Traders, Barchart, Invest.com, Morningstar, Stock News Journal, Stocktwits, Trading View, MarketWatch, Stockhouse and Insider Financial reported earlier on Delcath Systems, Inc. (DCTH), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Delcath Systems, Inc. is an interventional oncology Company focused on the treatment of primary and metastatic liver cancers. Its investigational product is Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The design of this product is to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Delcath Systems is based in New York, New York. The Company's shares trade on the OTCQB.
Delcath Systems has supported clinical research of liver directed high dose chemotherapy in patients with metastatic ocular and cutaneous melanoma, metastatic colorectal cancer, metastatic neuroendocrine tumors, and hepatocellular carcinoma. Liver directed high dose chemotherapy uses percutaneous hepatic perfusion (PHP) to deliver concentrated doses of a chemotherapeutic agent directly to the liver.
The Company's system has been commercially available in Europe since 2012 under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT). In Europe, it has been used at major medical centers to treat a broad array of cancers of the liver. Delcath is working on advancing its clinical programs of its unique Melphalan/HDS.
Melphalan/HDS has not been approved by the U.S. Food & Drug Administration (FDA) for sale in the United States. Additionally, Delcath is working to increase commercialization efforts for CHEMOSAT in Europe. The Company continues its focus on the clinical trials, which comprise the Clinical Development Program (CDP).
Delcath Systems has begun a worldwide Phase 3 FOCUS clinical trial for Patients with Hepatic Dominant Ocular Melanoma (OM). It plans to start a global registration trial for intrahepatic cholangiocarcinoma (ICC).
Earlier this month, Delcath Systems announced that it received medical device approval for the CHEMOSAT® Hepatic Delivery System (CHEMOSAT) from the national health authority in Brazil. This approval of CHEMOSAT as a Class 3 medical device was issued by the Agência Nacional de Vigilância Sanitária (ANVISA). It permits the marketing and utilization of CHEMOSAT under the same percutaneous intra-arterial administration of melphalan hydrochloride to the liver with subsequent extracorporeal filtration of blood indication, as in Europe.
Delcath Systems, Inc. (DCTH), closed Monday's trading session at $0.132, up 3.94%, on 599,438 volume with 162 trades. The average volume for the last 3 months is 220,239 and the stock's 52-week low/high is $0.109/$10.30.
TechCare Corp. (TECR)
InvestorsHub, MarketWatch, Stockhouse, OTC Markets, Investing, 4-Traders, GuruFocus, Morningstar, YCharts, Penny Stock Tweets, PR Newswire, Investors Hangout, Seeking Alpha, Wallet Investor, Stockwatch, Barchart, last10k, Dividend Investor, Emerging Growth, and Market Screener reported earlier on TechCare Corp. (TECR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
TechCare Corp. has an inventive delivery platform that utilizes vapor technology for natural health and beauty treatments. The Company engages in the design, development, and commercialization of this unique delivery platform using vaporization of different natural, plant-based compounds, to enable a wide variety of treatment solutions. A technology company and OTCQB-listed, TechCare is based in New York City.
The Company has a strategic partnership agreement with HoMedics, one of the world's leading brands in health and wellness products. HoMedics manufactures, markets, and distributes TechCare's Novokid products in the United States, Canada, Brazil, Argentina, Colombia, and Costa Rica. These products are co-branded as HoMedics products powered by TechCare.
Novokid consists of a portable device that vaporizes TechCare's all-natural, plant-based solution contained in a disposable capsule. It comes with a proprietary head cap. Novokid is 100 percent natural, plant-based and pesticide-free. Novokid is the first of its type home use device. It presents a scientifically proven solution to eliminate lice, super lice, as well as eggs.
Novokid uses a proprietary vapor-based delivery platform. TechCare's Novokid has received CE Mark approval as a CLASS I Medical Device. Novokid uses a simple 10-minute dry treatment. The treatment requires no rinsing or washing and is fast, dry, and clean. It is easily administered at home or while mobile. In addition, Novokid can be used as a maintenance and preventative treatment if used regularly.
The Company's Shine is a hair treatment device. It underwent development with globally renowned industry leaders. Shine cleanses the hair and scalp. It also rejuvenates hair by returning its natural health, shine, body and luster. The expectation is that Shine will launch later in 2019.
TechCare announced in May of 2018 that following intensive research and development (R&D) and investments, it expanded its existing Intellectual Property (IP) portfolio with a previously submitted patent application of its Smart Capsule™ technology. Building upon its existing patents and knowledge, the new Smart Capsule™ technology enables the vaporization of two or more compounds simultaneously. As a result, this expands the range of applications while yielding superior performance, usability and ease-of-use.
Last month, TechCare announced that on January 21, 2019, it entered into a joint venture (JV) contract with China-Israel Biological Technology Co. Ltd. (CIB). With this agreement, TechCare's subsidiary Novomic Ltd. and CIB agreed to create a Chinese JV company in China.
The JV will concentrate on the field of health and cosmetics, including medical care, home care, hair care, and body and skin care, to develop a comprehensive and extensive range of health, wellness, beauty and home products for customers by using TechCare's patented technology of vaporization of natural and plant-based compounds. The JV's intention is to sell its products in the Greater China region, including mainland China, Hong Kong, Macao and Taiwan, directly or through others.
TechCare Corp. (TECR), closed Monday's trading session at $0.236, up 7.27%, on 238,158 volume with 31 trades. The average volume for the last 3 months is 9,666 and the stock's 52-week low/high is $0.0401/$0.75.
Northsight Capital, Inc. (NCAP)
Awesome Penny Stocks, OTC Markets, InvestorsHub, GuruFocus, Insider Monkey, Stockopedia, Equity Clock, Marketwired, The Street, Equities, MarketWatch, Barchart, WhaleWisdom, Stockhouse, Simply Wall St, and Uptick Newswire reported previously on Northsight Capital, Inc. (NCAP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Northsight Capital, Inc. consists of a portfolio of online Cannabis-related websites that are undergoing development and operated by the Company. These sites incorporate numerous facets of the Cannabis industry. The Company is transitioning into two sectors. One is the Bitcoin ATM service industry. The other is its modern cannabis advertising and media platform. Northsight Capital is headquartered in Scottsdale, Arizona.
Northsight Capital does not sell or distribute any cannabis products. The Company is looking to acquire digital or publishing companies in the space. It has its 420Careers.com. This is a leading job site in the Cannabis space.
Northsight Capital also has its WeedDepot.com. This website provides consumers with a geo-targeted map directory of medical and recreational dispensaries, head shops, doctors, attorneys and more within the Cannabis industry. Weed Depot has a whole platform of content suited for every aspect of advertising and marketing to consumers from all businesses in the cannabis industry.
Northsight Capital earlier acquired Crush Mobile, LLC. Crush Mobile has developed a group of dating sites with a presence in the Latino, Israeli, and African American communities. Crush Mobile is a part of the Company's growing media group. Crush Mobile has incorporated into its dating applications suite Northsight Capital's "Joint Lovers" dating app that centers on the Cannabis space.
Northsight Capital reached an agreement in principal in 2018 to be the exclusive distributor of CBD products for SeniorsCBD, a brand of Seniors for CBD. Northsight Capital and Seniors for CBD signed an agreement in principal to create the first CBD product line specifically for the seniors' market. Seniors for CBD (www.SeniorsforCBD.com) is a leader in the industry for educating and informing seniors on the continuing research on medical marijuana and CBD through bringing current news each day to their followers.
This past December, Northsight Capital announced that it launched its new enhanced cannabis careers web site, www.420Careers.com. This site first launched in 2010. It is considered one of the foremost career sites in the cannabis arena. The site has been updated with many new more user-friendly features. These features make it easier for job seekers to post their resumes and also makes it easier for employers to access them. The 420Careers site has 2,000 to 3,000 visitors a day and roughly 1 million-page views per month.
This month, Northsight Capital announced an agreement in principal to be the master distributer of 3 exclusive lines of CBD products. The initial orders will be shipped early next month. The lines include earlier announced SeniorsCBD, specializing in formulas specifically for seniors, LiquidMD, a CBD infused water, LiquidMD for pets, and Nature Grown CBD, Northsight's generic brand.
The Company is expecting to receive the initial shipment of its CBD products on or about the first week of March. First distribution will be through Northsight's broad online media presence and also independent sales and distribution outlets.
Northsight Capital, Inc. (NCAP), closed Monday's trading session at $0.0036, up 38.46%, on 53,986,024 volume with 434 trades. The average volume for the last 3 months is 3,950,331 and the stock's 52-week low/high is $0.002/$0.0515.
MGX Minerals, Inc. (MGXMF)
Proactive Investors, Wall Street PR, InvestorsHub, Wallet Investor, Dividend Investor, Stockhouse, OTC Markets, MarketWatch, 4-Traders, Morningstar, Capital Equity Review, The Street, Stockwatch, Equities, StockInvest.us, The Streetwise Reports, Barchart, and Market Screener reported previously on MGX Minerals, Inc. (MGXMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
MGX Minerals, Inc. is a diversified resource company with its corporate headquarters in Vancouver, British Columbia. It centers on the development of large-scale industrial mineral portfolios in specific commodities and jurisdictions that will fuel the new energy economy. MGX Minerals controls considerable interest in lithium, magnesium and silicon assets throughout North America. The Company lists on the OTC Markets Group's OTCQB.
MGX Minerals' strategy is to identify commodities and jurisdictions where large-scale development opportunities exist. Additionally, the Company's strategy is to build its asset portfolio via aggressive acquisition to quickly build and enhance long-term portfolio value. Furthermore, its strategy is to engage industry experts to lessen execution risk and quickly increase time to market.
The Company has regional control in most of the industrial mineral projects in the jurisdictions it operates. Pertaining to near-term potential, MGX Minerals concentrates on assets that offer streamlined development timelines and low initial capital expenditures (capex). It has developed a proprietary, low-energy design process (Rapid Recovery Process) that is patent-pending. The design of it is specifically for highly-mineralized brine associated with oilfields. The process quickly concentrates lithium and other minerals in brine.
MGX Minerals has completed pilot plant testing in South America on brine samples originating from numerous salars in Chile. The Company entered into a joint brine testing agreement with several South American mining companies. The parties are working to identify potential joint-venture (JV) locations that will utilize MGX Minerals' lithium extraction technology.
Earlier this month, MGX Minerals and engineering partner PurLucid Treatment Solutions reported that a second deployment of an advanced wastewater treatment system is near completion and commissioning is anticipated soon. This system is capable of processing up to 10m3 per hour. The system will substantially decrease greenhouse gases through energy savings on steam generation. The technology provides superior treatment outcomes versus conventional technology that requires offsite trucking and high cost (because of toxicity) disposal. PurLucid Treatment Solutions' exclusively licensed and patented nanoflotation technology was designed purposely for oilfield environments.
This week, MGX Minerals reported that its collaborative research partnership with the University of British Columbia (UBC) completed a wide-ranging baseline assessment of metallurgical silicon originating from each of MGX's three silicon projects in southeastern British Columbia. The Company and UBC are working together to develop next-generation Li-ion batteries capable of quadrupling energy density from present 100 Wh/kg up to 400 Wh/kg for use in long-range electric vehicles and grid storage.
MGX Minerals, Inc. (MGXMF), closed Monday's trading session at $0.1964, up 3.75%, on 65,933 volume with 31 trades. The average volume for the last 3 months is 118,454 and the stock's 52-week low/high is $0.159/$1.079.
SilverSun Technologies, Inc. (SSNT)
NetworkNewsWire, Market Chameleon, Stocktwits, Marketwired, Proactive Investors, Zacks, Tip Ranks, Marketbeat, 4-Traders, The Street, Street Insider, InvestingNote, Business Insider, OTC Markets, Simply Wall St, InvestorsHub, and MarketWatch reported earlier on SilverSun Technologies, Inc. (SSNT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
SilverSun Technologies, Inc. is a business application, technology and consulting company. It provides strategies and solutions to meet its clients' information, technology, business management, and network and cybersecurity requirements. The Company's main operating subsidiary is SWK Technologies. SilverSun offers solutions for accounting and business management, financial reporting, Enterprise Resource Planning (ERP), Warehouse Management Systems, Customer Relationship Management (CRM), and Business Intelligence. The Company is headquartered in East Hanover, New Jersey.
In 2018, SilverSun Technologies' wholly-owned subsidiary, SWK Technologies, acquired Info Sys Management, Inc. (ISM). ISM is a leading Portland, Oregon-based reseller of Sage Software and Acumatica solutions. In addition, ISM provides hosting services for business applications to customers across the United States.
SilverSun Technologies engages in the acquisition and build-out of technology and software companies involved in providing transformative business management solutions and professional consulting services to small- and medium-sized businesses in the manufacturing, distribution and service industries. SilverSun also has its own development staff building software solutions for Electronic Data Interchange, time and billing and an array of ERP enhancements.
The Company's services and technologies deliver context-relevant insight and perspective into critical business operations. This enables SilverSun's clients to manage, protect and monetize their enterprise assets - on premise or in the cloud. The Company's proprietary, feature-rich and user-friendly EDI software is MAPADOC™. This software enables businesses to considerably cut data entry time through eliminating duplicate entries. The software also enables businesses to reduce costly errors with trading partners and to lessen mapping time by more than 75 percent.
Last month, SilverSun Technologies announced that subsidiary, SWK Technologies, acquired Partners in Technology, Inc. (PIT). PIT is a foremost reseller of Sage Software solutions, servicing more than 160 customers in the Chicago area.
Yesterday, SilverSun Technologies provided an update on its Cybersecurity-as-a-Service business launched in July of last year. The service is provided by its wholly-owned subsidiary, Critical Cyber Defense Corporation (CCDC), in partnership with CyberHat, a top Israeli Security Operations Center (SOC). The new cybersecurity service offering enables partners and customers to leverage SilverSun's leading security operations teams to meet their cybersecurity needs.
Moreover, yesterday, SWK Technologies announced that it now offers comprehensive application hosting services. BACH (Business Application Cloud Hosting) is an all-inclusive hosting service for ERP, CRM, network monitoring software, and other business management applications. It leverages secure cloud connections to maintain client systems through off-site servers. The service was added to SWK via the acquisition of Information Systems Management, Inc. (ISM) in 2018, and is now fully available to the SWK's customers.
SilverSun Technologies, Inc. (SSNT), closed Monday's trading session at $2.90, up 3.57%, on 1,865 volume with 12 trades. The average volume for the last 3 months is 7,491 and the stock's 52-week low/high is $2.00/$4.56.
Flexpoint Sensor Systems, Inc. (FLXT)
Tip Ranks, Business Insider, The Street, Stockhouse, Simply Wall St, Investopedia, Investing, Research and Markets, MarketWatch, Investors Hub, Uptick Newswire, Super Stock Screener, Equity Clock, Marketbeat, and Investor Place reported earlier on Flexpoint Sensor Systems, Inc. (FLXT), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Flexpoint Sensor Systems, Inc. is a technology company specializing in developing products that feature its patented Bend Sensor® and associated technology. The Bend Sensor's single-layer, thin film construction reduces expenses and mechanical bulk. It does so while introducing a range of functions and stylistic design possibilities that have never before been available in sensing technology. Flexpoint Sensor Systems is based in Draper, Utah and the Company lists on the OTC Markets.
The Company produces the Bend Sensor® for manifold applications, encompassing numerous markets. These markets include automotive and transportation, wearables, medical, industrial controls, consumer products, and toys/gaming. Flexpoint offers Consulting, Design, Development, and Manufacturing related to the adoption of the Bend Sensor® technology.
The Bend Sensor® product comprises a coated substrate, such as plastic, that changes in electrical conductivity as it is bent. Electronic systems connect to the sensor and measure with fine detail the amount of bending or movement that takes place. The single layer design of the Bend Sensor® eliminates many of the problems associated with conventional sensors. This includes dust, dirt, liquids, as well as heat and pressure effects.
Since early in 2017, Flexpoint Sensor Systems and CaptoGlove® started a strategic, collaborative relationship to deliver unique, integrated virtual reality/augmented reality (VR/AR) systems driven by Bend Sensors® to mass markets. Flexpoint continues its wide-ranging success in the Virtual Reality/Augmented Reality (VR/AR) market for Glove-Based Systems.
In June 2018, Flexpoint Sensor Systems announced two significant development opportunities. The opportunities involve the implementation of two of the Company's Bend Sensor® technologies for vehicles, and the development of its Bend® Sensor technology and its testing and proof of concept for tracking and monitoring the use of opioids.
Last week, Flexpoint Sensor Systems announced that it continues to receive production Purchase Orders from award-winning client/partners, including South Korea-based Neofect. This relationship, originally established in 2015/2016, brought to market smart, inventive, medical glove-based technologies, featuring the Flexpoint Bend Sensor®. Neofect produces the RAPAEL Smart Glove, which is a 2018 CES Innovation award winner.
Mr. Paul Sexauer, Flexpoint Sensor Systems' Vice President Sales and Marketing, said, "This is the type of client relationship we look to establish, nurture and grow. We are pleased to see the success of Neofect as they have become a part of our growing client/partner base, and we're honored to have the Bend Sensor® designed into these innovative technologies. The glove-based wearables (medical and VR/AR) market continues to be very exciting for us and one where we are clearly differentiated."
Flexpoint Sensor Systems, Inc. (FLXT), closed Monday's trading session at $0.03712, down 2.47%, on 19,001 volume with 3 trades. The average volume for the last 3 months is 55,357 and the stock's 52-week low/high is $0.029/$0.09.
Novo Resources Corp. (NSRPF)
Energy and Gold, The OTC Reporter, Spotlight Growth, MarketWatch, YCharts, Emerging Growth, Dividend Investor, Capital Cube, Investors Hangout, GuruFocus, Junior Mining Network, The Online Investor, OTC Markets, Insider Financial, Metals News, Streetwise Reports, 4-Traders, StockInvest, Mining Stock Valuator, Stockhouse, InvestorsHub, Finance Registrar, and Trading View reported on Novo Resources Corp. (NSRPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Novo Resources Corp.'s focus is to evaluate, acquire, as well as explore gold properties. Its current emphasis is to explore and develop gold projects in the Pilbara area of Western Australia. The Company has built up a considerable land package covering approximately 12,000 sq km. Novo Resources is based in Vancouver, British Columbia. The Company's shares trade on the OTC Markets' OTCQX.
Novo Resources also controls a 100 percent interest in approximately 2 sq kms encompassing much of the Tuscarora Au-Ag vein district in Nevada. The Company's current focus is its Beatons Creek and Marble Bar paleoplacer gold projects in Western Australia. Novo owns the roughly10 sq km Beatons Creek Tenements in Western Australia. Wide-ranging test work conducted on Beatons Creek conglomerates indicates high gravity recoveries.
The Company has the right to earn a 70 percent interest in the roughly 1,800 sq km Pilbara Paleoplacer Gold Project, which includes the Beatons Creek and Marble Bar paleoplacer gold projects, in Western Australia from the Creasy Group. In addition, Novo has acquired, via staking, a 100 percent interest in approximately 6,021 sq kms of mineral rights in the Karratha area. It staked exploration applications covering about 7,000 sq kms in the area around Karratha. The Company controls roughly an additional 2,000 sq kms elsewhere in the Pilbara region.
Regarding the Karratha Gold Project, Novo Resources entered into farm-in and joint venture (JV) agreements with Artemis Resources to earn-in on an additional 1,256 sq kms of mineral rights. Additionally, the Company entered into sale and purchase agreements and farm-in and JV agreements for an 80 percent interest in the Comet Well property. It also entered into an option agreement for 100 percent of Welcome Exploration's gold rights.
At the end of January, Novo Resources announced that it received encouraging results from initial testing of mechanical rock sorting of gold-bearing conglomerate from its Karratha gold project. The potential feasibility of mechanical rock sorting was tested by subjecting four bulk samples to crushing, screening, as well as sorting using a TOMRA mechanical rock sorter. Sorted rock concentrates of very small volume were generated returning high gold contents.
Last week, Novo Resources announced advancements in resource work including wireframe modeling and receipt of initial results from its bulk sampling program at its Beatons Creek project in Nullagine, WA. Final bulk sample assays are expected shortly. At that time, work on a new resource model will be completed. The Company anticipates announcing a new resource for Beatons Creek around the end of Q1 2019.
Novo Resources Corp. (NSRPF), closed Monday's trading session at $1.97, up 9.44%, on 175,627 volume with 137 trades. The average volume for the last 3 months is 96,463 and the stock's 52-week low/high is $1.42/$5.003.
Rise Gold Corp. (RYES)
StockChase, Junior Mining Network, Metals News, MarketWatch, Marketwired, 4-Traders, OTC Markets, Stockhouse, Epstein Research, GuruFocus, Canadian Insider, Streetwise Reports, Wallet Investor, and Market Screener reported earlier on Rise Gold Corp. (RYES), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Rise Gold Corp. is an exploration-stage mining company based in Vancouver, British Columbia. Its main asset is the historic past producing Idaho-Maryland (I-M) Gold Mine in California. The Idaho-Maryland Mine was a significant past producer, yielding 2.4M oz of gold. Rise Gold's shares trade on the OTC Markets Group's OTCQB.
The Idaho-Maryland Gold Mine property is fully-owned by Rise Gold. This includes surface and mineral rights. Rise Gold owns all the mineral rights. This Mine is near Grass Valley, California.
The Idaho-Maryland Gold Mine produced a total of 2,414,000 oz gold with an average mill head grade of 0.50oz/ton (about 17g/t). The Mine was producing up to 129,000 oz gold per year before being forced to shut down by the U.S. government in 1942. During WW II the U.S. War effort wanted to shut down precious metals excavation and shift the national mining workforce from gold to copper production.
Rise Gold announced in 2018 that it completed the purchase of 82 acres of fee-simple land (Mill Site Property) contiguous to the historic New Brunswick mine shaft. Total payments to acquire an undivided 100 percent interest in the Mill Site Property were US$1,900,000. Rise Gold invested US$3,900,000 for the purchase of private land in Nevada County, California. It bought the Mill Site Property to support the exploration and future development of the Idaho-Maryland (I-M) Gold Project.
This past December, Rise Gold announced additional assay results from continuing diamond core drilling at the Idaho-Maryland (I-M) Gold Project. The exploration drill program at the I-M Gold Project continues to be successful. Recent drilling tested a number of new targets that produced the highest-grade gold intercept to-date.
The first drill hole in 52 Vein area assays 149.3 gpt gold over 6.8 m. It confirms the 52 Vein area as a significant exploration target. As of December 13, 2018, drilling of the Idaho #1 Vein target was currently in-progress.
Rise Gold Corp. (RYES), closed Monday's trading session at $0.0769, up 3.92%, on 200,800 volume with 19 trades. The average volume for the last 3 months is 114,359 and the stock's 52-week low/high is $0.0351/$0.1218.
Planet 13 Holdings, Inc. (PLNHF)
MicroCap Daily, Wallet Investor, Pot Network, Penny Stock Hub, Markets and Research, InvestorX, MicroSmallCap, Market Screener, Stockhouse, MarketWatch, Dividend Investor, Trading View, Morningstar, Financial Content, and InvestorsHub reported earlier on Planet 13 Holdings, Inc. (PLNHF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Planet 13 Holdings, Inc. is a vertically integrated cannabis company listed on the OTCQB. It has award-winning cultivation, production, and dispensary operations in Las Vegas, Nevada. The Company is an established cannabis leader in the Nevada market. Its emphasis is on providing a premier dispensary experience and optimizing cultivation efficiencies via its best-in-class technology, as the frontline of cannabis. Planet 13 Holdings is headquartered in Las Vegas.
The Company's mission is to build a recognizable worldwide brand known for first-rate dispensary operations, and a creator of unique cannabis products. On November 1, 2018, Planet 13 opened the largest, most advanced retail dispensary in the world immediately next to the Las Vegas strip. The new facility features 16,200 sq. ft. of dispensary space.
Planet 13 has 6-plus Cannabis Licenses. It is fully licensed for cultivation, retail distribution and more in the fast developing Nevada market. The Company's Medizin dispensaries provide top quality recreational cannabis, cannabis extracts, and infused products. Medizin also centers on industry-leading customer experiences. It produces flower, concentrates, vape pens, edibles and more. Medizin (Medical) and Planet 13 (Recreational) brands are already some of the most awarded cannabis product brands in Nevada.
Planet 13 announced in November of 2018 that it launched its second wholly-owned brand, TRENDI. TRENDI represents expertly crafted disposable vape and concentrate products. Fundamentally, they create the trend, not the other way around. TRENDI employs state-of-the-art hydro carbon extraction technology further refined by fractional distillation. It delivers a very high potency product. The TRENDI line of products will be exclusive to the Planet 13 Superstore. TRENDI will be powered by a curated array of strains, processed into ultra-premium disposable vapes and concentrates at Planet 13's production facilities.
Earlier this month, Planet 13 announced that in January it served an average of 1,550 customers per day at its Superstore in Las Vegas versus 1,430 customers per day in December. This represents a month-over-month increase of 8.4 percent. In addition, Planet 13 stated that its average ticket size for the month was higher than expected.
Furthermore, this month, Planet 13 commended the proposal by Governor Sisolak to establish the Cannabis Compliance Board (CCB) that will review recent licensing procedures. This includes the most recent licensing round announced on December 5, 2018. Moreover, the CCB will oversee the development of future legislation including that governing consumption lounges.
Planet 13 Holdings, Inc. (PLNHF), closed Monday's trading session at $2.44613, up 11.27%, on 856,138 volume with 874 trades. The average volume for the last 3 months is 209,083 and the stock's 52-week low/high is $0.5015/$2.669.
Petro River Oil Corp. (PTRC)
Market News Updates, Real Investment Advice, The Street, Corporate Information, Simply Wall St, Oil Voice, Wolf Street, OTC Stock Review, InvestorsHub, MarketWatch, Streetwise Reports, The Energy Report, Stockhouse, Wallet Investor, GuruFocus, Market Screener, Morningstar, 4-Traders, and YCharts reported earlier on Petro River Oil Corp. (PTRC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Petro River Oil Corp. utilizes 3D seismic technology to discover and develop oil and gas reserves in proven oil and gas basins. The Company's core acreage is positioned in Osage County, Oklahoma. Petro River Oil owns a 14.52 percent equity interest in Horizon Energy Partners, LLC. Additionally, its President, Mr. Stephen Brunner, is a member of the Board of Managers of Horizon Energy Partners, LLC. An independent oil and gas exploration company, Petro River Oil is based in New York, New York. The Company also has an office in Kingwood, Texas.
Petro River Oil's Management team has drilled more than 800-plus successful wells in the vicinity of the Company's 87,754 acre Pearsonia West Lease Concession in Osage County, Oklahoma. Management's historic success rate in the area is 90 percent.
Petro River Oil's emphasis is on high rate return assets. The Company's strategy is to apply modern technology, including 3D Seismic analysis, to exploit hydrocarbon-prone resources in historically prolific plays and underexplored prospective basins. This is to build reserves and to create value for Petro River Oil and its shareholders.
Petro River Oil has successfully drilled three additional wells and discovered two new oil fields in Osage County, Oklahoma since the end of April 2018. These are the North Blackland field and the Arsaga field. The success of the Company's most recent exploration well, the Arsaga 25-2, was announced in July of 2018. Preliminary results indicated 30 feet of productive Mississippian Chat formation, with an estimated ultimate recovery of 50,655 barrels of oil equivalent based on the Reserve Report.
The Arsaga field is Petro River Oil's largest oil field discovery with about 2,000 prospective acres and up to 100 well locations. With the success of the Arsaga field, and the West and North Blackland fields, the Company anticipates significant cash flow from oil and gas production this year.
At the end of July 2018, Petro River Oil announced its year end April 30, 2018 financials and 2018 guidance. Highlights include a 1,131 percent increase in oil and gas production in fiscal year 2018 from fiscal year ending April 30, 2017. Company production ramped up, with greater than 60 percent of the new production occurring in Q4.
Highlights also include a 395 percent increase in proved and probable reserves in fiscal year 2018 per the May 1, 2018 evaluation (Reserve Report) by independent engineering firm Cawley, Gillespie & Associates. Moreover, highlights include an 11.27 percent decrease in general and administrative expenses for fiscal year 2018.
Petro River Oil Corp. (PTRC), closed Monday's trading session at $0.50, up 2.04%, on 30,007 volume with 25 trades. The average volume for the last 3 months is 8,583 and the stock's 52-week low/high is $0.3073/$1.75.
InPlay Oil Corp. (IPOOF)
Zacks, OTC Markets, Private Capital News Wire, InvestorsHub, Stockhouse, Uptick Newswire, Penny Stock Hub, Energy Now, Dividend Investor, GuruFocus, Market Screener, Stockwatch, MarketWatch, Barchart, Wallmine, InvestorX, TradingView, The Street, Wallet Investor, and 4-Traders reported previously on InPlay Oil Corp. (IPOOF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
InPlay Oil Corp. is a growth-oriented light oil development and production company. It focuses on large oil in place pools with low recovery factors, low declines, and long life reserves mainly targeting the Cardium Formation in the Province of Alberta. The Company's light oil focus properties provide high netbacks with fast payout on new drills. OTCQX-listed, InPlay Oil is based in Calgary, Alberta.
The Company's Cardium assets are situated in West Central Alberta centered in the Pembina and Willesden Green pools. These pools have large oil in place reserves. In addition, there are still large reserves of unrecovered oil.
InPlay Oil's Belly River light oil property is on the east side of the Pembina Cardium Pool. Belly River growth opportunities are concentrated around targeting oil in tight sands with low recovery factors through drilling horizontal multi-frac wells.
The Company also holds rights on a developing Duvernay light oil play. Depths are only a little more than that of the Cardium sand in Willesden Green. This results in well costs that are manageable for InPlay Oil.
Last month, InPlay Oil announced that its Board of Directors approved a $36 million Exploration and Development capital program for 2019. The approved 2019 capital program includes the completion of the two deferred horizontal wells drilled in Q4 of 2018 and also drilling roughly nine net horizontal wells with most being ERH Cardium wells in the Company's core Willesden Green bioturbated play.
In 2018, InPlay Oil drilled 16 (11.2 net) horizontal wells in the Willesden Green area. This includes 12 (8.6 net) extended reach horizontal wells (ERH) and 4 (2.6 net) one-mile horizontal wells.
In the Duvernay, InPlay Oil completed its first horizontal well and drilled one vertical stratigraphic test well. The result is estimated annual average production of about 4,650 boe/d (70 percent oil and liquids), which attains production growth of roughly 17 percent over 2017 (22 percent for oil and liquids). This exceeds the Company's recently increased annual production guidance of 4,600 boe/d following the two prior increases to production guidance in the second half of last year.
InPlay Oil Corp. (IPOOF), closed Monday's trading session at $0.812, up 6.84%, on 13,000 volume with 8 trades. The average volume for the last 3 months is 14,213 and the stock's 52-week low/high is $0.6209/$1.5273.
Integrated Cannabis Company, Inc. (ICNAF)
Awesome Penny Stocks, Market News Updates, Wallet Investor, Trading View, The Venture Report, Market Chameleon, BioSpace, Wallstreet Online, Investors Hangout, MarketWatch, InvestorsHub, Stockwatch, Stockhouse, OTC Markets, CannaBizNetwork, and Barchart reported previously on Integrated Cannabis Company, Inc. (ICNAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Integrated Cannabis Company, Inc.'s focus is health and creating health and lifestyle products utilizing advanced delivery systems and formulations. The Company comprises dedicated scientists and product engineers. It was previously known as CNRP Mining, Inc. It changed its name to Integrated Cannabis Company, Inc. in June of last year. Integrated Cannabis Company is based in Vancouver, British Columbia. The Company's shares trade on the OTC Markets Group's OTCQB.
The Company's X-SPRAYS™ product line consists of eight market ready orally ingested spray products. Four products available are infused with hemp-based cannabidiol (CBD). Four products are formulated without a cannabidiol (CBD) infusion.
The products are highly bioavailable; the active ingredients in the sprays are already completely dissolved. Therefore, the vitamins and minerals do not need to be further broken down once swallowed. They are immediately available for use by the body.
The X-SPRAYS™ product line is packaged in precise, metered dose and convenient spray tubes. This includes a child-resistant version. Integrated Cannabis Company's products are made in Arizona. Its CBD is hemp derived from Colorado.
In September 2018, Integrated Cannabis Company announced the completion of a market ready Tetrahydrocannabinol (THC)-infused spray product and the required licensure for manufacturing of the product in the State of Colorado. The THC product uses the same nanotechnology used to enhance the CBD-infused X-SPRAYS™. This results in higher bioavailability and quicker uptake in comparison to capsules or powder.
Recently, Integrated Cannabis Company announced that X-SPRAYS™ successfully exhibited at the 2019 Athens Cannabis Expo in Greece in January at the Tae Kwon Do Convention Center in Athens, Greece. The Expo took place January 11-13, 2019 in Athens. It attracted industry leaders from across the European Union (EU) and other parts of the world. X-SPRAYS™ was on display and the Company's sales team successfully educated the public on their novel formulations and delivery method.
Mr. John Knapp, Integrated Cannabis Company's Chief Executive Officer, said, "The Athens Cannabis Expo was an excellent opportunity for X-SPRAYS™ to network with EU cannabis businesses and to expand our European distribution channels.The European market showed us great promise in 2019 for CBD products. We are positioning ourselves to take full advantage of the changing landscape this year and believe Europe will be a pivotal component for our growth."
Integrated Cannabis Company, Inc. (ICNAF), closed Monday's trading session at $0.2713, up 1.95%, on 64,539 volume with 46 trades. The average volume for the last 3 months is 129,764 and the stock's 52-week low/high is $0.1958/$1.58.
The QualityStocks Company Corner
- VPR Brands, LP (VPRB)
- Pressure BioSciences Inc. (PBIO)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- Genprex Inc. (NASDAQ: GNPX)
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
- Cannabis Strategic Ventures, Inc. (NUGS)
- Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
- SinglePoint, Inc. (SING)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Green Hygienics Holdings Inc. (GRYN)
- ChineseInvestors.com (CIIX)
- Generation Alpha, Inc. (GNAL)
- Millennial Lithium Corp. (TSX.V: ML) (FSE: A3N2) (OTC: MLNLF)
VPR Brands, LP (VPRB)
VPR Brands, LP (OTC PINK: VPRB), a market leader in innovation specializing in accessories and vaporizers for cannabis concentrates and extracts as well as cannabidiol (CBD), will be officially launching its premium GOLDLINE CBD Brand and CBD website https://cbdgoldline.com.
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed the day's trading session at $0.07, up 1.45%, on 80,303 volume with 13 trades. The average volume for the last 3 months is 71,511 and the stock's 52-week low/high is $0.026/$0.1397.
- GOLDLINE CBD Brand 40% Off Site-Wide in Celebration of the 2018 Farm Bill
- VPR Brands Letter to Shareholders 2018
- VPR Brands, LP Announces Third Quarter 2018 Results
Pressure BioSciences Inc. (PBIO)
Uptick Newswire recently welcomed Dr. Bradford A. Young, Senior Vice President and Chief Commercial Officer of Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or "the Company") to The Stock Day Podcast. PBI is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. The interview was hosted by Mr. Everett Jolly.
Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.
The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.
Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”
Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.
The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.
Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.
This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.
The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.
Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.89, up 12.75%, on 23,110 volume with 73 trades. The average volume for the last 3 months is 15,842 and the stock's 52-week low/high is $1.52/$4.09.
- Uptick Newswire Hosts Dr. Bradford A. Young of Pressure BioSciences, Inc., on The Stock Day Podcast to Discuss the Commercialization of PBI's Proprietary UST and BaroFold Technology Platforms
- CBD-Infused Beverages Achieve Quality and Clarity Breakthrough Utilizing Pressure BioSciences' Ultra Shear Technology Platform
- Pressure BioSciences Looks to Disrupt the Life Sciences Sector with Its Novel Technologies
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in the 420 with CNW by CannabisNewsWire. Barely a month ago, Gov. DeSantis signed a bill to allow patients to smoke medical marijuana after protracted legal battles which ended when court ruled that banning smokable marijuana was unconstitutional. Now a bill to regulate the strength of the smokable medical marijuana has been passed by a House committee amidst protests by medical cannabis advocates.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.42, up 0.59%, on 56,054 volume with 181 trades. The average volume for the last 3 months is 204,129 and the stock's 52-week low/high is $1.8068/$5.205.
- 420 with CNW – Florida Moves to Regulate the Potency of Smokable Medical Cannabis
- CBD Infused Product Companies Look To "Go Where The Consumers Already Are"
- Five Stocks to Watch as Legal Marijuana Evolves
Genprex Inc. (NASDAQ: GNPX)
Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, reported that its collaborators from The University of Texas MD Anderson Cancer Center ("MD Anderson") presented positive preclinical data for the combination of the TUSC2 gene with an anti-PD1 antibody, pembrolizumab, for the treatment of lung cancer in a poster presented at the American Association of Cancer Research Meeting 2019. The TUSC2 gene is a tumor suppressor gene, the active agent in Genprex's Oncoprex™ immunogene therapy.
Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.
Research and Development
Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.
Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.
Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.
Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.
TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.
Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.
Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.
Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.
Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.
Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.
Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.
Genprex Inc. (NASDAQ: GNPX), closed the day's trading session at $1.8101, up 3.67%, on 39,897 volume with 101 trades. The average volume for the last 3 months is 48,544 and the stock's 52-week low/high is $0.95/$19.45.
- Genprex Collaborators Report Positive TUSC2 and Checkpoint Blockade Preclinical Data at the 2019 AACR Annual Meeting
- NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Posts Clinical, Corporate and Financial Update
- Genprex Provides Clinical, Corporate, and Financial Update for the Year Ending December 31, 2018
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
Automotive technology innovator Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) this morning announced that its QuadSight vision system was recognized at the prestigious 2019 Edison Awards, being named the 'Gold Winner' of the 'Transportation & Logistics, Autonomous Vehicles' category. To view the full press release, visit http://nnw.fm/gk45R.
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.
Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.
The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.
Foresight has developed three main products:
- QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
- Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
- Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.
In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.
Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.
Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.
Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.
Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $1.35, up 4.65%, on 34,343 volume with 86 trades. The average volume for the last 3 months is 59,711 and the stock's 52-week low/high is $1.25/$4.43.
- NetworkNewsBreaks – Foresight Autonomous Holdings Ltd.'s (NASDAQ: FRSX) (TASE: FRSX) QuadSight Named 'Gold Winner' at 2019 Edison Awards
- Foresight Receives Notice of Allowance for First Patent Application from U.S. Patent and Trademark Office
- NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Releases Financial Results for Q4 and Full Year 2018
Cannabis Strategic Ventures, Inc. (NUGS)
As California tax and fee regulators celebrate the approximately $300 million in sales and excise tax receipts brought in during the first year of recreational marijuana legalization in the state, Los Angeles-based Cannabis Strategic Ventures Inc. (OTC: NUGS) is honing its focus on supporting entrepreneurial growth within the fast-expanding industry through active buy-in by the company's varied subsidiaries. NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company's newsroom at http://nnw.fm/NUGS.
Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.
The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.
Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.
Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.
Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.
Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.
Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.
The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.
Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.08, up 0.15%, on 20,606 volume with 42 trades. The average volume for the last 3 months is 112,174 and the stock's 52-week low/high is $1.05/$5.94.
- Cannabis Strategic Ventures Inc. (NUGS) Growing in the Heart of California's Cannabis Cropland
- Cannabis Strategic Ventures Inc. (NUGS) Subsidiaries Carving Out Key Positions within Booming Cannabis Industry
- 420 with CNW – Demand for Medical Cannabis Skyrockets on Rhode Island
Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company") is pleased to announce that it has hired Ogilvy Canada ("Ogilvy") as its integrated brand development agency. Ogilvy is a global award-winning creative agency that does brand work for Fortune Global 500 companies as well as local businesses across 131 offices in 83 countries. Ogilvy's Toronto office will deliver world-class creative and impactful communications strategies to promote the launch of Sproutly's brands into the Canadian cannabis market.
Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.
To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.
This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.
Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.
Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.
Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.
Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.
President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.
Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.
Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.
Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.
Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.60, up 2.01%, on 887,270 volume with 359 trades. The average volume for the last 3 months is 489,252 and the stock's 52-week low/high is $0.189/$1.875.
- Sproutly Set to Build Strong Brands by Bringing on Award-Winning Agency Ogilvy
- NetworkNewsBreaks – Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) Fostering Innovation in the Cannabis Industry
- Sproutly Receives Processing License from Health Canada
SinglePoint, Inc. (SING)
SinglePoint Inc. (OTCQB: SING), a fully reporting technology company providing mobile payments, ancillary cannabis services and renewable energy solutions, this morning announced the filing of its first annual report with the SEC as a fully reporting issuer. To view the full press release, visit http://nnw.fm/dGS3Q. Also today, the company was highlighted in an article by 24/7 Market News.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis' SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint's bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout's subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original "Shark Tank" member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet's secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary's product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation's largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint's chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed the day's trading session at $0.0156, up 1.63%, on 5,893,351 volume with 172 trades. The average volume for the last 3 months is 4,229,546 and the stock's 52-week low/high is $0.0106/$0.068.
- NetworkNewsBreaks – SinglePoint Inc. (SING) Files First Annual Report with SEC, Reports 344% YOY Revenue Increase
- Venture Breakfast Bits, by 24/7 Market News
- NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses NASDAQ Listing Goal on MoneyTV with Donald Baillargeon
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
With massive markets such as California officially coming on line at the beginning of 2018, there has been a boost coming from innovators such as Plus Products Inc. (OTC:PLSPF) (CSE:PLUS), whose proprietary infused gummies are dominating the California edibles market. The days of the Canadian advantage in the cannabis sector could be coming to an end with the recent passing of the US Secure and Fair Enforcement (SAFE) Banking Act by the House Financial Services Committee.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed the day's trading session at $3.89, off by 2.26%, on 134,197 volume with 260 trades. The average volume for the last 3 months is 80,284 and the stock's 52-week low/high is $2.81/$6.008.
- Innovation and New Banking Bill Could Surge US Cannabis Companies Permanently Ahead of Canadian Counterparts
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Reveals Impressive Revenue Growth in Unaudited Revenue Estimate of FY2018
- NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Launches Mango CBD Relief Product Containing 90mg CBD and 10mg THC
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a report by VirtualInvestorConferences.com, as that source has made the presentations from its April 4th, 2019 conference available for on-demand viewing https://www.virtualinvestorconferences.com/.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.21, off by 1.83%, on 760,481 volume with 1,077 trades. The average volume for the last 3 months is 1,430,816 and the stock's 52-week low/high is $1.607/$7.894.
- OTC Company Investor Presentations Now Available for On-Demand Viewing
- NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Strengthens Commitment to Clean Cannabis Production with Additional Organic Certification
- Cannabis Stocks to Watch: Green Organic Dutchman (OTCQX:TGODF) Down -6.98% Wednesday
Green Hygienics Holdings Inc. (GRYN)
Green Hygienics Holdings Inc. (GRYN) was featured today in the 420 with CNW by CannabisNewsWire. Barely a month ago, Gov. DeSantis signed a bill to allow patients to smoke medical marijuana after protracted legal battles which ended when court ruled that banning smokable marijuana was unconstitutional. Now a bill to regulate the strength of the smokable medical marijuana has been passed by a House committee amidst protests by medical cannabis advocates.
Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.
The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.
Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.
Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.
Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.
The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.
Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.
Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.63995, off by 0.01%, on 9,001 volume with 10 trades. The average volume for the last 3 months is 29,517 and the stock's 52-week low/high is $0.07/$0.722.
- 420 with CNW – Florida Moves to Regulate the Potency of Smokable Medical Cannabis
- NetworkNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Plans to Purchase Ranch as Potential Cultivation Site
- NetworkNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Eyeing Potential to Expand Yield Capabilities, Overall Market Presence
With 20 years of tested experience, ChineseInvestors.com Inc. (OTCQB: CIIX) is a leading financial information website for Chinese-speaking investors in both the United States and China. The company has a highly diversified revenue stream and is working to further establish itself as a recognized leader in the hemp-based cannabidiol (CBD) oil industry. CIIX is laying groundwork to capitalize on the U.S. demand for CBD-based nutrition and health products.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed the day's trading session at $0.4754, off by 0.96%, on 58,625 volume with 46 trades. The average volume for the last 3 months is 77,137 and the stock's 52-week low/high is $0.365/$1.25.
- ChineseInvestors.com Inc. (CIIX) Building Brand Recognition, Creating New Products
- 420 with CNW – Demand for Medical Cannabis Skyrockets on Rhode Island
- 420 with CNW – Ontario Marijuana Stores Open as Fines Loom
Generation Alpha, Inc. (GNAL)
Generation Alpha, Inc. (OTCQB: GNAL) ("Generation Alpha" or the "Company"), a vertically integrated cannabis technology innovator, manufacturer and distributor, announces the closing of a significant transaction for the Company with the purchase of an approximately 46,000 sq. ft. facility in Phoenix, Arizona. This facility comes with an already- approved Special Use Permit (SUP) for the cultivation and processing of medical cannabis in the State of Arizona and is ideally located less than 10 miles from Phoenix's Sky Harbor International Airport.
Generation Alpha, Inc. (GNAL) was established in 2010 as a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to both commercial and individual growers in the United States. Originally named Solis Tek Inc., the company changed its name to Generation Alpha in September 2018 and announced an increased focus on providing innovative and must-have cannabis products and services to a growing industry.
“Generation Alpha for us means ‘new beginning’” said Generation Alpha CEO Alan Lien, when the name change was announced. “It is the new wave of how people and brands connect. We are excited with the transformation of our business strategy, our progress at our Arizona facility and the additional growth opportunities our team has identified elsewhere in the cannabis industry. While we are pleased with our innovation and progress in our Solis Tek lighting and Zelda Horticulture divisions, we believe?Generation Alpha?represents our philosophy of bringing the best cannabis products and services to the market. We are confident that this shift in our business strategy will create long-term shareholder value through diversified segments in the legalized cannabis industry.”
The name change reflects the company’s strategy to leverage business opportunities in different legalized cannabis spaces, including cultivation, processing and retail facilities. As part of that focus, Generation Alpha acts as the holding entity for a collection of companies that bring products and solutions to legal retail and commercial cannabis growers while utilizing its expertise to offer safe, quality and consistent products through its cultivation, processing, and retail facilities as well as branded products in both the medical and recreational markets. Along with its strong focus on the burgeoning cannabis market, Generational Alpha remains committed to developing and providing innovative products and services in both Solis Tek Digital Lighting, its lighting division, and Zelda Horticulture, its agricultural products division.
As part of a key piece of its cannabis focus, Generation Alpha acquired a cannabis cultivation and processing facility in Phoenix, Arizona, which is scheduled to begin operation in 2019. Currently in the design and development stage, the 70,000-square-foot facility will be one of the most technologically advanced cultivation and processing facilities in Arizona, which is a hot bed of cannabis cultivation in North America. Generation Alpha management is confident about the growth and profitability this facility provides as an essential component of its forward-thinking cannabis strategy.
Additional components of this strategy include the company’s GrowPro Solutions, Inc., a nationwide cannabis cultivator and processor and a variety of Generation Alpha brands, which include the innovation, design and selling of cannabis?products such as flower, oils and accessories in the legal medical and recreational markets.
The company’s Zelda Horticulture division offers commercial-grade rolling tables, greenhouses, PH stabilizer and nutrient products, and other agricultural products for cultivators around the world. Zelda’s custom-design cultivation options means its clients can count on increased agricultural productivity and efficiency.
Generation Alpha’s Solis Tek Digital Lighting division offers an extensive line of lighting equipment and accessories, including digital ballasts, reflectors,?complete lighting systems, single- and double-ended digital lamps, controllers and other accessories.?Each product is designed to help retail and commercial growers maximize quality and achieve higher yields and maximize quality.?
Generation Alpha, Inc. (GNAL), closed the day's trading session at $0.32, off by 6.43%, on 141,230 volume with 47 trades. The average volume for the last 3 months is 74,350 and the stock's 52-week low/high is $0.259/$1.549.
- Generation Alpha Launches into the Legal U.S. Medical Cannabis Industry with the Purchase of an Arizona Property to be Used as a Cultivation and Processing Facility
- 420 with CNW – Cerebral Palsy Added to Michigan Medical Cannabis Qualifying Conditions
- 420 with CNW – New York City Legislators Consider Banning Pre-Employment Cannabis Tests
Millennial Lithium Corp. (TSX.V: ML) (FSE: A3N2) (OTC: MLNLF)
Millennial Lithium Corp. (TSX.V: ML) (FSE: A3N2) (OTC: MLNLF) is engaged in the development of the Pastos Grandes lithium project in Salta Province, Argentina. The company’s Pastos Grandes project totals approximately 10,000 hectares located in geopolitically stable, mining-friendly jurisdictions. The company also enjoys a solid strategic partnership with GCL, a Chinese solar giant that has become Millennial Lithium’s lead investor with approximately $30 million investment to date.
Millennial Lithium’s compelling valuation places it with a $123 million market cap, third only to Lithium Americas and Orocobre in the region. The company holds a strong cash position of C$40 million and is pursuing a strategic plan moving forward in 2019 that includes an updated NI 43-101 resource report and a full bankable feasibility study, including supporting evaporation ponds and pilot processing plant.
Argentina currently produces 17 percent of the world’s lithium supply. Lithium is at the cornerstone of a quiet industrial revolution as it brings together energy, automotive and technologies companies to foster a lasting move away from carbon-based resources. Lithium demand is expected to grow at an annual rate of 22 percent through 2025 with increased demands for lithium-ion batteries used in electric vehicles and battery-based energy storage leading the way.
Millennial Lithium has a world-class lithium brine asset strategically located in the heart of the Argentinean portion of the South American “Lithium Triangle.”
The company’s flagship lithium brine project, Pastos Grandes, is following a two-year timeline to production as a result of some of the best infrastructure in the Lithium Triangle. Located 231 km from the city of Salta at an elevation of 3,800 meters, Pastos Grandes is accessible year-round with all-weather access to paved highways, power and natural gas. Based on proven technology, brine extraction, solar evaporation and conventional lithium brine processing, Millennial Lithium’s preliminary economic assessment (PEA) of the Pastos Grandes project, completed by international engineering firm WorleyParsons, estimates a mine life of 25 years with a three-year ramp up to 25,000 tonnes per year of Lithium-Carbonate. A 3 tonne-per-month lithium carbonate pilot plant is currently being built for use at the site.
To date, 23 exploration wells are completed with $40 million spent in development. A revised Resource Estimate is planned for Q1 2019. Four pumping wells are also to be completed in Q1 2019 with two water wells currently being drilled in support of the ongoing Feasibility Study, also being completed by WorleyParsons. Infrastructure buildup is underway, including completion of a 40-man camp, hybrid solar-diesel power system, pilot plant and laboratory with ICP unit for rapid sample assays and a liming plant for treating concentrated brines form the pilot ponds. Millennial Lithium is also constructing a Pastos Grandes community center/warehouse and all-purpose building that is central to building community relations with local residents.
Encouraging results from an extended pumping test of a second production-scale well at the Pastos Grandes project revealed that at a pumping rate of 15 liters/second (L/s), the lithium content remained consistent over the 23-day trial period with a drawdown of approximately 57 meters with rapid recovery. Estimated transmissivity (the rate at which the brine moves through the aquifer) is 40 square meters per day, demonstrating the aquifer’s strong potential to sustain a long-term pumping rate of 15 L/s.
Brine sampling completed daily during the pumping test over the 23-day period revealed the chemistry is consistent with lithium ranging from 482 mg/L and 518 mg/L, averaging 495 mg/L. The best lithium values occurred during the last five days of the pumping test. The magnesium to lithium (Mg/Li) ratio averages 5.3 and the average potassium to lithium ratio (K/Li) is 10.5 and the average sulphate to lithium ratio (SO4/Li) is 16.4. Sampling was conducted in accordance with CIM guidelines for brine resource evaluation, with an appropriate chain of custody and QA/QC program in place for ensuring veracity, accuracy and precision of the analytical results.
Millennial Lithium’s highly prospective lithium assets and strategies are bolstered by a world class management and board with extensive experience in lithium and large development projects.
President/CEO/Director Farhad Abasov, MBA, has founded and managed a number of mining aassets with successful exits in the last few years. He was president and CEO of Allana Potash which was sold to Israel Chemicals Ltd. for $170 million in 2015. As executive chairman of Rodinia Lithium, Abasov developed lithium bring projects in Argentina in 2016. He was also co-founder of Potash One, acquired by German potash company K+S for $430 million in 2010, and was senior vice president, strategy, at Energy Metals, acquired by Uranium One for $1.88 million in 2007.
Iain Scarr, BSc., MBA, is Chief Operating Officer with a wealth of experience in lithium brine development and operations. He worked at Rio Tinto, industrial minerals, including lithium resource development in Serbia. Scarr led feasibility work at Sal de Vida lithium brine project (Galaxy Resources, Argentina); completed the Rincon lithium brine project feasibility study (Enirgi, Argentina); and is a resident of Salta with established, strong relationships in the region.
Chief Financial Officer Max Missiouk, CPA, CMA, has served as a CFP and controller for a number of publicly listed resource and venture companies including Allana Potash Corp. and Crocodile Gold Corp. He is a CPA (CMA) and has a post-graduate degree in banking and finance management.
Peter J. MacLean, Ph.D., P.Geo, is senior vice president, technical services. He has more than 30 years of exploration and development experience in North America, South America and Africa. Most recently, MacLean acted as senior vice president/exploration of Allana Potash Corp. and directed all exploration and development activities on its flagship Danakhil Potash Project in Ethiopia including managing the company’s Feasibility Study and overseeing pilot solution mining and evaporation pond trials. He has also worked extensively on projects throughout the Americas and is fluent in Spanish.
Peter Ehren, M.Sc., AusIMM CP, process consultant, has been involved in lithium brines for more than 20 years. Ehren has worked at the Salar de Atacama as part of SQM’s team of leading evaporation technology experts, rising to the position of R&D manager. He has worked in the majority of lithium basins worldwide for numerous projects including Orocobre’s Salar de Olaroz Project.
Millennial Lithium Corp. (OTC: MLNLF), closed the day's trading session at $1.2073, up 4.08%, on 11,400 volume with 13 trades. The average volume for the last 3 months is 13,674 and the stock's 52-week low/high is $0.67/$2.369.
- Millennial Reports Positive Pumping Test Results from Third Production Scale Well at Pastos Grandes Project, Argentina; Investor Relations and Communications / Branding Agreements
- Millennial Commissions Renewable Energy-Powered On-Site Development Park at Their Flagship Pastos Grandes Lithium Project; Caution Regarding Recent Online Article Concerning the Company
- Millennial Lithium Corp. (TSX.V: ML) (FSE: A3N2) (OTCQX: MLNLF) is "One to Watch"
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Announces Upsizing, Closing of Second and Final Tranche of Private Placement
- Cannabis Strategic Ventures, Inc. (NUGS) Subsidiaries Carving Out Key Positions within Booming Cannabis Industry
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) 420 with CNW – Demand for Medical Cannabis Skyrockets on Rhode Island
- ChineseInvestors.com (CIIX) 420 with CNW – Ontario Marijuana Stores Open as Fines Loom
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) Canada Prepares for 420: Canadian Cannabis Companies Open Their Doors for April
- City View Green Holdings Inc. (CSE: CVGR) Partners with Leading Jamaican Blue Mountain Coffee Company
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Why Cool Events Is ‘One to Watch’
- Earth Science Tech, Inc. (ETST) Strategy of Targeting Pharmacies for Cannabidiol Products Dovetails with Analysis of CBD Market
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) 420 with CNW – Ireland Finally Selects a Medical Marijuana Supplier
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF) Confirms Mineralization in 150-metre Step Out Hole and Announces Private Placement
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Receives Notice of Allowance for First Patent Application from U.S. Patent and Trademark Office
- Genprex Inc. (NASDAQ: GNPX) Posts Clinical, Corporate and Financial Update
- Global Consortium, Inc. (OTC: GCGX) is adding a Medical Grade Nutraceutical's Division
- Generation Alpha, Inc. (GNAL) 420 with CNW – New York City Legislators Consider Banning Pre-Employment Cannabis Tests
- Global Payout, Inc. (GOHE) and MTrac Expand to Deliver Solutions to Oregon and Hawaii Markets
- Golden Developing Solutions, Inc. (DVLP) DVLP to Host World's Largest 420 Festival with Launch of "Shared Festival" Event
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) CBD Infused Product Companies Look To "Go Where The Consumers Already Are"
- Green Hygienics Holdings Inc. (GRYN) Plans to Purchase Ranch as Potential Cultivation Site
- Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) Announces Smart Innovations
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) DehydraTECH Technology Revolutionizes CBD Delivery
- Marijuana Company of America Inc. (MCOA) Latest Report Shows Quickly Increasing Number Of Consumers Using CBD Infused Products
- Medical Cannabis Payment Solutions (REFG) to Open Customer Service Center
- Millennial Lithium Corp. (TSX.V: ML) (FSE: A3N2) (OTCQX: MLNLF) Reports Positive Pumping Test Results from Third Production Scale Well at Pastos Grandes Project, Argentina; Investor Relations and Communications / Branding Agreements
- MustGrow Biologics Corp. is “One to Watch”
- Net Element, Inc. (NASDAQ: NETE) Subsidiary Offers Innovative POS Solutions to Restaurant Industry
- Nightfood, Inc. (OTCQB: NGTF) Announces Highest Revenue Quarter in Company History, National Roll-Out On Track as Ice Cream Secures Distribution in Fifteen States During Q1
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Provides Business Update
- Pacific Software, Inc. (PFSF) Recognized as One of the‘20 Most Promising AGTECH Solution Providers – 2019 by CIOReview
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) 5 Companies Prepared to Dominate U.S. Hemp-infused Beverages
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Closing of Resource Acquisition
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Reveals Impressive Revenue Growth in Unaudited Revenue Estimate of FY2018
- Pressure BioSciences Inc. (PBIO) CBD-Infused Beverages Achieve Quality and Clarity Breakthrough Utilizing Pressure BioSciences' Ultra Shear Technology Platform
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) on Track for Growth as Lithium Demand Increases
- Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) Increases Stake in Mary's Wellness Ltd. through Equity-for-Debt Swap
- Sharing Services Global Corporation (SHRG) Commences Trade under New Stock Symbol
- SinglePoint, Inc. (SING) CEO Discusses NASDAQ Listing Goal on MoneyTV with Donald Baillargeon
- Spectrum Global Solutions, Inc. (SGSI) Posts Q4, Full Year 2018 Financial Results
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Fostering Innovation in the Cannabis Industry
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Announces Closing of $11.4 Million Bought Deal Including Partial Exercise of Over-Allotment Option
- Sugarmade, Inc. (SGMD) Featured in CannabisNewsAudio Publication on Demand for Hydroponics in Surging Hemp Market
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Microgrid Marijuana Mover to Put on Your Radar
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Releases Q4 and Full Year 2018 Results
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Strengthens Commitment to Clean Cannabis Production with Additional Organic Certification
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Set to Thrive within Blossoming Cosmeceutical Industry
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Closes C$16 Million Brokered Private Placement
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Subsidiary Receives Health Canada Approval for Vanluven Road Facility Expansion
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Builds Monetization with HelloMD Delivery Agreement
- Youngevity International, Inc. (NASDAQ: YGYI) Featured in CannabisNewsAudio Publication on Rise of Organic CBD Market
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.